
    
      Following angiography, patients with significant diameter stenosis >50% and lesion length (>
      25mm) requiring single or multiple long-stent placement (total stent length >28mm) by visual
      estimation and eligible for LONG-DES III trial inclusion and exclusion criteria will be
      randomized 1:1 to a) sirolimus-eluting and b) everolimus-eluting stent by the stratified
      randomization method.
    
  